• Photo Female liquid vaginal suppositories SCHALI®-FE in disposable single-dose container, front side Photo Female liquid vaginal suppositories SCHALI®-FE in disposable single-dose container, front side
  • Photo Female liquid vaginal suppositories SCHALI®-FE in disposable single-dose container, backside Photo Female liquid vaginal suppositories SCHALI®-FE in disposable single-dose container, backside
  • Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, front side Show box Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, front side Show box
  • Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, stiker, backside Show box Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, stiker, backside Show box
  • Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, backside Show box Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, backside Show box
  • Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, opened Show box Photo Female liquid rectal suppositories SCHALI®-FE, 16 PCs, opened Show box
  • Photo Female liquid rectal suppositories SCHALI®-FE, 80 PCs, opened cardboard box "T" #5 Photo Female liquid rectal suppositories SCHALI®-FE, 80 PCs, opened cardboard box "T" #5
  • Photo Female liquid rectal suppositories SCHALI®-FE, 80 PCs, closed cardboard box "T" #5 Photo Female liquid rectal suppositories SCHALI®-FE, 80 PCs, closed cardboard box "T" #5

Female liquid rectal suppositories SCHALI®-FE

SKU: SFEH0000
450

Available

Bonus points:
1

Price as configured: 0.00 €

Payment Method: payment

Quick Overview

SCHALI®–FE Liquid Rectal Suppositories are a photoactive product intended to induce immunity and blood supply in scope of complex treatment and prevention of endocrine and lymphatic system disorders. The product is intended for personal care purposes, has preventive action and may be used as complex therapy and photodynamic therapy agents in treatment of a wide range of endocrine and lymphatic system disorders for lower vascular penetrability, less oedema and inflammation in the thyroid gland.
  • Instruction
  • Specification
  • Composition
  • Reviews

Instruction

Instruction

Instructions for Use
Personal Prophylactic Hygiene Care
Female Liquid Rectal Suppositories
SCHALI® Care–FE
Endocrine Disorders

 

SCHALI® Care–FE Liquid Rectal Suppositories are a photoactive product intended to induce immunity and blood supply in scope of complex treatment and prevention of endocrine and lymphatic system disorders.

 

PRODUCT FORM:

Prophylactic hydrogel in 3 ml disposable single-dose container.

 

INGREDIENTS:

Aqua, Hydroxypropyl Cyclodextrin, Glycerin, Propylene Glycol, Glycereth-18 Ethylhexanoate, Glycereth-18, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Titanium Dioxide, Triethanolamine, Diazolidinyl Urea, Methylparaben, Propylparaben, Phosphoric Acid.

 

MECHANISM OF ACTION:

Soft hydrogel formulation of the suppositories dissolves slowly in the rectum, where it is absorbed by rectal mucosa. The product acts locally by inducing regeneration, strengthening vascular walls and improving microcirculation in capillaries.

Regular use of the product induces immune response and improves cellular exergy exchange, resulting in better cellular lifeline and regeneration.

Mineral bio-constituent of the hydrogel formulation includes fragments of a certain class of metalloid semiconductors with unsaturated bonds - titanium dioxide crystalline lattice - known for its high catalytic activity. Photoactive particles of QD SCHALI® titanium dioxide trigger generation of active oxygen forms (singlet oxygen). Mechanism of action is based on the principle of energetic neutralization of free chemical bonds on the surface of toxic compounds by saturating them with complementary oxygen atoms, generated in the result of the catalytic reaction. Active oxygen forms may successfully treat most of all currently known exogenous and endogenous intoxications.

Besides, active oxygen forms (singlet oxygen) trigger mechanism of activation in serotonin receptors, leading to better regulation of serotonin reuptake inhibition by selectively blocking serotonin absorption in presynaptic membrane. Re-balanced serotonin level helps in restoring homeostasis and ceasing thanatogenesis, promotes female health and function of endocrine system, improves cellular metabolism and condition of blood vessels, and contributes to better immune response.

The product is intended for personal care purposes, has preventive action and may be used as complex therapy and photodynamic therapy agents in treatment of a wide range of endocrine and lymphatic system disorders for lower vascular penetrability, less oedema and inflammation in the thyroid gland.

Hypoallergenic product.

 

INDICATIONS:

  • Obesity
  • Diabetes conditions
  • Thyroiditis
  • Thyrotoxicosis

 

METHOD OF USE:

For rectal use only.

Take one single-dose container out of the package with clean hands, insert into the rectum and press out its content, while lying on your side. Apply one suppository 2 times a day for one month. Extend your course of treatment up to 90 days, if necessary.

 

SIDE EFFECTS:

No side effects found.
No product dependence and no rebound syndrome.

 

CONTRAINDICATIONS:

Do not use during pregnancy.
No other contraindications detected.

 

STORAGE CONDITIONS:

Keep the product in a dark cool place at the temperature below 25°С.

 

SHELF LIFE:

Shelf life is 3 years from the date of production.
Do not use the product after expiration of the date of production, specified on the package.

 

SCHALI® Care Personal Hygiene Products are made under license No. 286-S.

Specification

Series

SCHALI® Care

Application area

Better Health, Endocrinology

Prescription

Diabetes, Endocrine disorders, High weight, Metabolic disorders, Thyroid disease

Release Form

Liquid suppositories

Sex

Female

Tank type

Individual single-use dispenser

Container capacity

3 ml

Product gross weight, kg

0.003

Product net weight, kg

0.048 ±5%

Method of application

Rectal

Primary package #1

Individual single-use dispensing device

Size of primary package #1 (L х W), mm

140 х 20

Net weight of primary package #1, kg

0.003

Gross weight of primary package #1, kg

0.010

Primary package #1 number, pcs

1

Consumer package #1

Foil bag №1

Size of consumer package #1 (L х W), mm

215 х 45

Net weight of consumer package #1, kg

0.003

Gross weight of consumer package #1, kg

0.012

Consumer package #1 number, pcs

1 disposable single-dose container

Consumer package #2

Show box #16

Size of consumer package #2 (L х W), mm

215 х 120 х 63

Net weight of consumer package #2, kg

0.048

Gross weight of consumer package #2, kg

0.380

Consumer package #2 number, pcs

16 disposable single-dose containers in foil bag

Freight package #1

3 layers cardboard box "T" #5

Size of freight package #1 (L х W), mm

345 х 225 х 135

Freight package #1 net weight, kg

0.24

Freight package #1 gross weight, kg

2.10

Freight package #1 number, pcs

5 show boxes #16

Freight package #2

5 layers cardboard box "P" #2

Size of freight package #2 (L х W), mm

365 х 295 х 245

Freight package #2 net weight, kg

0.480

Freight package #2 gross weight, kg

4.74

Freight package #2 number, pcs

2 pcs 3 layers cardboard boxes "T" #5 / 10 Show boxes №16

Freight package #3

Pallet #56

Size of freight package #3 (L х W), mm

1200 х 800 х 1500

Freight package #3 net weight, kg

26.88

Freight package #3 gross weight, kg

280

Freight package #3 number, pcs

56 pcs 5 layers cardboard boxes "P" #2 / 560 Show boxes #16

Shelf life

36 months from the date of production

Storage conditions

Should be stored in intact packaging at a temperature not exceeding +25°С

Country of Manufacture

Poland

Composition

Composition

Composition

  • Aqua
  • Hydroxypropyl Cyclodextrin
  • Glycerin
  • Propylene Glycol
  • Glycereth-18 Ethylhexanoate
  • Glycereth-18
  • Acrylates/C10-30 Alkyl Acrylate Crosspolymer
  • Titanium Dioxide
  • Triethanolamine
  • Diazolidinyl Urea
  • Methylparaben
  • Propylparaben
  • Phosphoric Acid

Reviews